CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of 8.64 million. The enterprise value is 8.66 million.
| Market Cap | 8.64M |
| Enterprise Value | 8.66M |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 184.79 million shares outstanding. The number of shares has increased by 7.32% in one year.
| Shares Outstanding | 184.79M |
| Shares Change (YoY) | +7.32% |
| Shares Change (QoQ) | +5.73% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.00% |
| Float | 184.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 3.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.42 |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 19.78.
| Current Ratio | 1.12 |
| Quick Ratio | 0.19 |
| Debt / Equity | 19.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.98% and return on invested capital (ROIC) is -32.72%.
| Return on Equity (ROE) | -78.98% |
| Return on Assets (ROA) | -12.51% |
| Return on Capital (ROIC) | -32.72% |
| Revenue Per Employee | 368,512 |
| Profits Per Employee | -58,791 |
| Employee Count | 43 |
| Asset Turnover | 1.69 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.22% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +0.22% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 46.31 |
| Average Volume (20 Days) | 229,006 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, CV Sciences had revenue of 15.85 million and -2.53 million in losses. Loss per share was -0.02.
| Revenue | 15.85M |
| Gross Profit | 7.30M |
| Operating Income | -1.88M |
| Pretax Income | -2.53M |
| Net Income | -2.53M |
| EBITDA | -1.62M |
| EBIT | -1.88M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 477,000 in cash and 496,000 in debt, giving a net cash position of -19,000 or -0.00 per share.
| Cash & Cash Equivalents | 477,000 |
| Total Debt | 496,000 |
| Net Cash | -19,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 2.51M |
| Book Value Per Share | 0.01 |
| Working Capital | 701,000 |
Cash Flow
| Operating Cash Flow | -708,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 46.06%, with operating and profit margins of -11.85% and -15.95%.
| Gross Margin | 46.06% |
| Operating Margin | -11.85% |
| Pretax Margin | -15.97% |
| Profit Margin | -15.95% |
| EBITDA Margin | -10.24% |
| EBIT Margin | -11.85% |
| FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.32% |
| Shareholder Yield | -7.32% |
| Earnings Yield | -33.75% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -11.68. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.68 |
| Piotroski F-Score | n/a |